Hand Eczema: Occupational and Chronic Hand Dermatitis

Clinical Overview

Hand eczema represents a heterogeneous group of inflammatory conditions affecting the hands, encompassing irritant contact dermatitis, allergic contact dermatitis, atopic hand eczema, and other subtypes. The condition is one of the most common occupational skin diseases, affecting 5-15% of workers in wet occupations (healthcare, food service, hairdressing, metalworking) and 1-2% of the general population. Hand eczema develops as a consequence of chronic exposure to irritants or allergens in combination with frequent wetting, mechanical trauma, or both. Unlike hand eczema in atopic individuals which often begins with systemic atopy, occupational hand eczema typically develops in response to specific workplace exposures and barrier disruption. The condition presents with variable morphology ranging from acute vesicular dermatitis to chronic lichenified plaques with significant functional impairment. Many patients with occupational hand eczema experience substantial morbidity including pain, bleeding from fissures, compromised hand function, and potential permanent occupational disability if not adequately managed. Early intervention and workplace modification are critical to prevent progression to chronic, disabling disease.

Epidemiology

Hand eczema affects 2-10% of the general population, with substantially higher prevalence (15-30%) in workers in wet occupations including healthcare, food service, hairdressing, metalworking, and cleaning industries. Incidence is highest in workers aged 30-50 years with cumulative occupational exposure. Female predominance is significant in some populations (female-to-male ratio 1.5-2:1), particularly in healthcare and hairdressing occupations where women predominate. The condition shows economic impact through work disability: approximately 20% of patients with severe hand eczema require occupational change, and economic costs (including direct medical costs and lost productivity) are substantial. Risk factors significantly increasing incidence include: working in wet occupations (10-20 fold increased risk), frequent handwashing and water exposure, contact with irritants (soaps, detergents, solvents, resins, metals), contact with known allergens (nickel, latex, potassium dichromate), atopic history (personal or family), history of previous hand eczema, and genetic predisposition (familial clustering observed in 20-30%). Age of onset varies: in atopic individuals, hand eczema often manifests in childhood or adolescence, while occupational hand eczema typically develops after years of exposure (peak onset 25-45 years). Geographic variation exists related to occupational structure and climate (cold, dry climates increase disease risk through barrier disruption).

Pathophysiology

The pathophysiology of hand eczema involves impaired skin barrier function, frequent water exposure, and immune-mediated inflammatory response. The hands are exposed to numerous occupational and environmental stressors: frequent contact with water (the single most important risk factor), irritants (soaps, detergents, cleaning agents, solvents, resins), allergens (nickel, latex, potassium dichromate, preservatives), and mechanical trauma. Frequent water exposure disrupts the stratum corneum barrier through multiple mechanisms: water penetrates and hydrates the barrier, causing physical swelling and disruption of intercellular lipid structure; surfactants in soaps and detergents penetrate the stratum corneum and solubilize intercellular lipids; repeated cycles of wetting and drying cause osmotic stress. The barrier disruption allows both increased water loss and increased penetration of irritants and allergens. Occupational irritants cause direct inflammatory response through TLR activation and inflammatory cytokine release (TNF-α, IL-1β, IL-6, IL-8). Allergens in occupational exposures (nickel from tools or equipment, latex from gloves, chromium from cement or metalworking fluids, fragrance preservatives) trigger Type IV delayed-type hypersensitivity reactions in sensitized individuals, with T lymphocyte-mediated inflammatory response. Genetic predisposition to barrier dysfunction (filaggrin mutations, altered lipid composition) increases susceptibility. Atopic individuals show inherent barrier dysfunction; approximately 30-40% of hand eczema cases in atopic individuals derive from occupation-related exposures in genetically predisposed individuals. Histologically, lesions demonstrate spongiosis, acanthosis, and inflammatory infiltrate; chronic lesions show lichenification and potentially fibrosis. Recurrent barrier disruption and inflammation drive progression from acute, reversible disease to chronic, potentially permanent changes.

Clinical Presentation

Hand eczema presents with variable morphology depending on disease stage and subtype. Acute disease manifests with erythema, edema, pruritus, and variable vesiculation on the palms, dorsal hands, or both. Chronic disease presents with lichenified plaques, marked scaling, fissuring, and often hyperpigmentation. The distribution pattern may suggest etiology: irritant contact dermatitis typically affects dorsal hands and fingers (areas of direct contact with irritants and greatest water exposure), while allergic contact dermatitis may show localized pattern related to specific allergen source (e.g., nickel dermatitis under fingers if nickel-containing tools are handled). Dyshidrotic eczema specifically affects palms and soles with vesiculation (discussed separately). Associated symptoms include pruritus (variable severity), burning or stinging sensations (particularly if fissuring is present), and significant pain if fissures are deep. Functional impairment is common: patients may have difficulty grasping objects (if palm surfaces affected), unable to perform fine motor tasks, pain with writing or other hand-dependent work. Secondary bacterial infection occurs in 15-25% of cases from traumatic inoculation. The course of hand eczema is highly variable: some patients experience acute flares with intervening periods of remission, while others develop chronic persistent disease. Seasonal variation is common, with winter exacerbations predominating due to xerosis and cold temperatures. Many patients report disease worsening with increased occupational stress and improved symptoms during vacation periods.

Diagnosis

Diagnosis of hand eczema requires clinical assessment of morphology, distribution, and occupational/environmental context. Key diagnostic criteria include: (1) acute or chronic inflammation of hands with erythema, edema, scaling, and/or fissuring; (2) temporal relationship to occupational exposures or water contact; (3) distribution pattern consistent with exposure (dorsal hands for irritant, localized for allergic); (4) response to topical corticosteroids and barrier repair. Patch testing should be performed to identify contact allergen sensitization, particularly in patients with suspected allergic contact dermatitis or occupational exposures (nickel, chromium, latex, preservatives). The International Contact Dermatitis Research Group (ICDRG) standard series with extended panels relevant to occupational exposures (metalworkers, hairdressers, healthcare workers) is recommended. Photosensitivity testing may be performed if photoallergic dermatitis is suspected. Prick testing for aeroallergens or occupational airborne allergens may be considered if history suggests environmental trigger. Potassium hydroxide (KOH) preparation and fungal culture should be obtained to exclude candida or dermatophyte infection, which may coexist with or mimic eczema. Bacterial culture is indicated if secondary infection is suspected. Skin biopsy is rarely necessary but demonstrates spongiosis, acanthosis, and inflammatory infiltrate. Detailed occupational history is essential: patients should describe specific job duties, materials handled, frequency of water exposure, protective equipment use, and temporal relationship between occupational activities and symptom exacerbation. Assessment of atopic history (personal history of atopic dermatitis, asthma, allergic rhinitis or family history) may guide prognosis and management.

Treatment Algorithm

Treatment of occupational hand eczema requires comprehensive approach addressing occupational exposures, barrier repair, and anti-inflammatory therapy. Success depends on workplace modification and patient adherence.

Occupational assessment and modification are critical. Detailed review of job duties, irritant and allergen exposures, and protective equipment is necessary. Specific modifications include: minimizing water exposure (using waterless hand sanitizers instead of frequent handwashing when appropriate, using dry cleaning materials instead of wet methods), use of protective gloves (powder-free latex-free gloves for healthcare workers, cotton-lined gloves under chemical-resistant gloves to minimize water accumulation), use of barrier creams before work (though evidence is mixed, some products may provide limited protection), and substitution of less irritating or allergenic products when possible. Occupational dermatologists can provide workplace consultation and hazard assessment. Identification of specific allergen sensitization through patch testing allows targeted allergen avoidance (e.g., switch from latex to nitrile gloves if latex-allergic).

Barrier repair is essential. Patients should avoid unnecessary water exposure; when handwashing is necessary, use lukewarm water and mild, fragrance-free cleansers. Immediately after water exposure (ideally within 1-3 minutes), emollients should be applied liberally. Recommended formulations include thick creams and ointments: CeraVe Moisturizing Cream, Eucerin Lotion or Cream, or plain petrolatum applied 2-3 times daily and after water exposure. Products containing ceramides, glycerin, and hyaluronic acid enhance barrier repair. Occlusive ointments including petrolatum or lanolin-based products provide superior barrier protection compared to lotions. Some patients benefit from nighttime occlusion: applying thick emollient and then sleeping with cotton gloves to enhance penetration and provide 8-12 hours of continuous moisturization.

Topical corticosteroids reduce inflammation acutely. Medium-potency agents are appropriate for body areas: triamcinolone acetonide 0.1% cream applied twice daily, or clobetasol propionate 0.05% ointment twice daily for severe disease (limited to 7-10 days due to potential for skin atrophy from occlusion and repeated topical application on hands). Dorsal hand skin is thicker than facial skin and tolerates higher potency agents. Fingertips and webbing spaces should be treated with lower potency agents (hydrocortisone 1%) due to thinner epidermis.

Topical calcineurin inhibitors including tacrolimus 0.1% ointment twice daily or pimecrolimus 1% cream twice daily are excellent steroid-sparing alternatives, particularly for maintenance therapy and long-term use. These agents do not cause skin atrophy with chronic use and are particularly beneficial for patients requiring frequent topical therapy.

Pruritus management may include first-generation antihistamines at bedtime (hydroxyzine 25-50 mg) to improve sleep quality and reduce nocturnal scratching. Topical antipruritics including pramoxine 1% lotion or menthol 1-2% provide temporary relief. Cool soaks in water (30-40°C) or application of cool compresses reduce inflammation and pruritus, though patients must be counseled to apply emollient immediately afterward to prevent water loss.

Systemic corticosteroids are rarely necessary for hand eczema unless extensive, severe disease significantly impairs hand function. Prednisone 0.5-1.0 mg/kg/day (maximum 60 mg daily) may be used briefly during severe flares to allow inflammation control while topical therapy takes effect, followed by rapid taper over 2-3 weeks. Systemic corticosteroids should not be used for maintenance.

For chronic, refractory hand eczema inadequately responsive to topical therapy and occupational modification, systemic immunosuppressive agents may be considered. Cyclosporine 2.5-5.0 mg/kg/day demonstrates efficacy in 60-80% of patients with severe chronic hand eczema; response is evident within 2-4 weeks. Azathioprine 1.5-2.5 mg/kg/day is an alternative with slower onset. Mycophenolate mofetil (MMF) 1000-1500 mg twice daily shows promise in recent studies.

Secondary bacterial infections require prompt management. Culture-guided antibiotic therapy is preferred; empiric treatment with oral cephalexin 500 mg four times daily or clindamycin 300-450 mg three times daily for 10-14 days is appropriate. For MRSA-positive cultures, trimethoprim-sulfamethoxazole (TMP-SMX) double-strength tablet twice daily or doxycycline 100 mg twice daily is recommended.

Prognosis

The prognosis of hand eczema is variable, influenced significantly by occupational factors and disease chronicity at presentation. Approximately 50-60% of patients with acute occupational hand eczema achieve complete remission with appropriate occupational modification and topical therapy. However, 30-40% of patients develop chronic, persistent disease requiring ongoing maintenance therapy. Factors influencing prognosis include: successful identification and elimination of specific occupational irritants or allergens, feasibility of workplace modification (some jobs cannot be modified without occupational change), patient adherence to barrier repair and emollient use, underlying atopic predisposition (atopic individuals generally have worse prognosis), disease chronicity at presentation (long-standing disease has poorer prognosis), and psychological coping (patients with high stress perception have worse outcomes). Early intervention prevents progression to severe, disabling disease; patients with acute hand eczema treated promptly have significantly better outcomes compared to those with delayed diagnosis. Approximately 15-20% of patients with moderate-to-severe hand eczema require occupational change if workplace modification is insufficient. In patients successfully treated with systemic immunosuppressive therapy, approximately 60-70% maintain improvement with topical maintenance therapy alone after systemic agents are discontinued.

When to See a Dermatologist

Initial dermatologic evaluation is appropriate for all hand eczema to confirm diagnosis and perform patch testing if allergic contact dermatitis is suspected. Urgent evaluation is indicated if: (1) severe disease causing significant functional impairment; (2) signs of cellulitis or systemic infection; (3) severe pain from fissuring; (4) occupational disability is imminent. Ongoing specialist care is appropriate if: (1) patch testing is needed; (2) disease does not respond to standard topical therapy within 3-4 weeks; (3) occupational assessment and workplace consultation is needed; (4) systemic therapy is being considered; (5) disease is recurrent despite apparent occupational modification.

Frequently Asked Questions

Q: Can I prevent hand eczema if I work in a wet occupation? A: Yes, the risk of developing hand eczema can be significantly reduced through preventive measures: minimizing unnecessary water exposure, using mild cleansers, applying barrier creams before work, using protective gloves, and applying emollients immediately after water exposure. Early intervention if symptoms develop can prevent progression to severe disease.

Q: Should I switch jobs if I have occupational hand eczema? A: Job change should be considered only after thorough trial of occupational modification, topical therapy, and potentially systemic therapy. Many patients achieve control with appropriate workplace adjustments. However, if disease is severe and unresponsive to all interventions, occupational change may be necessary to prevent permanent disability.

Q: Is barrier cream effective for hand eczema? A: Barrier creams provide limited protection compared to proper glove use and occupational modification. While some evidence suggests modest benefit, they should not be relied upon as primary prevention. Proper glove use, minimizing water exposure, and consistent emollient application provide more substantial protection.

Q: Can I continue working if I have hand eczema? A: Many patients can continue working with appropriate occupational modification and treatment. However, disease severity and ability to modify job duties significantly influence this decision. Consultation with occupational health professionals and dermatologists can assess workplace feasibility and recommend specific accommodations.

References